公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2005 | A potential role of YC-I on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse models | Pan S.-L.; JIH-HWA GUH ; Peng C.-Y.; Chang Y.-L.; Cheng F.-C.; Chang J.-H.; Kuo S.-C.; Lee F.-Y.; Teng C.-H. | Thrombosis and Haemostasis | 32 | 31 | |
2015 | A proposed mother-friendly childbirth model for Taiwanese women and obstetricians' attitudes toward it | Li Y.-P.; SHIN-YU LIN ; Yeh C.-H.; HENG-CHENG HSU ; YA-LING YANG ; CHIEN-NAN LEE ; Kuo S.-C. | Taiwanese Journal of Obstetrics and Gynecology | 2 | 1 | |
2015 | A proposed mother-friendly childbirth model for Taiwanese women, the implementation and satisfaction survey | Li Y.-P; Yeh C.-H; SHIN-YU LIN ; TAI-CHANG CHEN ; YA-LING YANG ; CHIEN-NAN LEE ; Kuo S.-C. | Taiwanese journal of obstetrics & gynecology | 5 | 2 | |
2007 | Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways | Chen Y.-C.; Lu P.-H.; Pan S.-L.; Teng C.-M.; Kuo S.-C.; Lin T.-P.; Ho Y.-F.; Huang Y.-C.; JIH-HWA GUH | Biochemical Pharmacology | 58 | 59 | |
2014 | Sheltering effect and indirect pathogenesis of carbapenem-resistant Acinetobacter baumannii in polymicrobial infection | Liao Y.-T.; Kuo S.-C.; Lee Y.-T.; Chen C.-P.; SHU-WEN LIN ; LI-JIUAN SHEN ; Fung C.-P.; Cho W.-L.; Chen T.-L. | Antimicrobial Agents and Chemotherapy | 35 | 34 | |
2020 | Studies of Coumarin Derivatives for Constitutive Androstane Receptor (CAR) Activation | Juang S.-H.; Hsieh M.-T.; Hsu P.-L.; Chen J.-L.; Liu H.-K.; Liang F.-P.; Kuo S.-C.; Chiu C.-Y.; SHING-HWA LIU ; Chou C.-H.; Wu T.-S.; Hung H.-Y. | Molecules (Basel, Switzerland) | 3 | 3 | |
2015 | Suramin inhibits chikungunya virus entry and transmission | Ho Y.-J.; Wang Y.-M.; Lu J.-W.; Wu T.-Y.; LIANG-IN LIN ; Kuo S.-C.; Lin C.-C. | PLoS ONE | 59 | 52 | |
2008 | Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agents | Lien J.-C.; Wu C.-R.; Hour M.-J.; Huang L.-J.; TUR-FU HUANG ; Kuo S.-C. | Archiv der Pharmazie | 3 | 3 | |
2005 | YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G 0-G1 in human hepatocellular carcinoma cells | Wang S.-W.; Pan S.-L.; JIH-HWA GUH ; Chen H.-L.; Huang D.-M.; Chang Y.-L.; Kuo S.-C.; Lee F.-Y.; Teng C.-M. | Journal of Pharmacology and Experimental Therapeutics | 47 | 47 | |
2005 | YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models | Pan S.-L.; JIH-HWA GUH ; Peng C.-Y.; Wang S.-W.; Chang Y.-L.; Cheng F.-C.; Chang J.-H.; Kuo S.-C.; Lee F.-Y.; Teng C.-M. | Journal of Pharmacology and Experimental Therapeutics | 55 | 53 | |
2006 | YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9 | Liu Y.-N.; Pan S.-L.; Peng C.-Y.; JIH-HWA GUH ; Huang D.-M.; Chang Y.-L.; Lin C.-H.; Pai H.-C.; Kuo S.-C.; Lee F.-Y.; Teng C.-M. | Journal of Pharmacology and Experimental Therapeutics | 39 | 33 | |
2007 | YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-κB in microglia | Lu D.-Y.; Tang C.-H.; Liou H.-C.; Teng C.-M.; Jeng K.-C.G.; Kuo S.-C.; Lee F.-Y.; WEN-MEI FU | British Journal of Pharmacology | 57 | 55 | |
2008 | YC-1 induces heat shock protein 70 expression and prevents oxidized LDL-mediated apoptosis in vascular smooth muscle cells | Liu Y.-N.; Pan S.-L.; Peng C.-Y.; Huang D.-Y.; JIH-HWA GUH ; Kuo S.-C.; Lee F.-Y.; Teng C.-M. | Shock | 12 | 10 | |
2007 | YC-1 inhibits HIF-1 expression in prostate cancer cells: Contribution of Akt/NF-κB signaling to HIF-1α accumulation during hypoxia | Sun H.-L.; Liu Y.-N.; Huang Y.-T.; Pan S.-L.; Huang D.-Y.; JIH-HWA GUH ; Lee F.-Y.; Kuo S.-C.; Teng C.-M. | Oncogene | 162 | 158 | |
2005 | YC-1 suppresses constitutive nuclear factor-κB activation and induces apoptosis in human prostate cancer cells | Huang Y.-T.; Pan S.-L.; JIH-HWA GUH ; Chang Y.-L.; Lee F.-Y.; Kuo S.-C.; Teng C.-M. | Molecular Cancer Therapeutics | 45 | 43 | |
2013 | Yuwen02f1 suppresses LPS-induced endotoxemia and adjuvant-induced arthritis primarily through blockade of ROS formation, NFkB and MAPK activation | Hsu C.-C.; Lien J.-C.; Chang C.-W.; Chang C.-H.; Kuo S.-C.; TUR-FU HUANG | Biochemical Pharmacology | 78 | 75 |